2. (1) Subject to subsections (3) to (5), the following drugs that are manufactured for use in livestock are designated as livestock medicines for the purposes of the Act and this Regulation: 1.  Preparations for the control of external and internal parasites and insect pests. 2.  Oral preparations for the prevention or treatment of disease of the digestive system, including bloat, colic, indigestion, diarrhea, constipation and impaction. 3.  Preparations for the treatment of surface wounds and lacerations, wire cuts and burns. 4.  Preparations for the treatment of skin diseases, including topical hoof care products. 5.  Vitamins for injection or oral administration, including injectable vitamin A, not to exceed 500,000 International Units per millilitre and injectable vitamin D, not to exceed 75,000 International Units per millilitre. 6.  Preparations for the prevention or treatment of deficiencies, including hematinics for horses, containing, i.  minerals for oral administration, ii.  selenium for injection, or iii.  iron for injection. 7.  Propylene glycol and preparations, including dextrose, calcium, phosphorus and magnesium preparations, for the treatment and prevention of acetonemia and hypocalcemia or otherwise intended as an aid in the supportive treatment of nutritional deficiencies. 8.  Implants and feed additives for use as growth promotants. 9.  Anti-cannibalism compounds for use in poultry. 10.  Topical preparations for use as liniments, counterirritants and poultices for the treatment of joint pain and swollen ligaments, tendons or muscles. 11.  Oral or topical preparations for use as antitussives, decongestants, bronchodilators and expectorants. 12.  Acetylsalicylic acid boluses for use in horses and cattle. 13.  Disinfectants, udder washes, teat dips and sanitizers. 14.  Antimicrobials, including their salts and derivatives. O. Reg. 465/18, s. 2. (2) Subject to subsection (4), a veterinary biologic is designated as a livestock medicine for the purposes of the Act and this Regulation, unless it is exempted under subsection (5), if the veterinary biologic was, (a)  imported into Canada pursuant to a permit issued under section 121 of the Health of Animals Regulation (Canada); or (b)  manufactured pursuant to a product licence issued under section 124 of the Health of Animals Regulation (Canada) and it is permitted to be sold under that Regulation. O. Reg. 465/18, s. 2. (3) A drug set out in subsection (1) shall not be designated as a livestock medicine unless it has been assigned a drug identification number pursuant to subsection C.01.014.2 (1) of the Food and Drug Regulations (Canada). O. Reg. 465/18, s. 2. (4) A drug that is prescribed by subsection 3 (2) of Ontario Regulation 264/16 (General) made under the Drug and Pharmacies Regulation Act as being in Schedule I for the purposes of the Drug and Pharmacies Regulation Act is not designated as a livestock medicine. O. Reg. 465/18, s. 2. (5) The following veterinary biologics are not designated as livestock medicines: 1.  Anthrax vaccine. 2.  Brucella vaccine. 3.  Rabies vaccine. 4.  Modified-live virus and live virus vaccines for use in mammals, except the following veterinary biologics: i.  IBR-PI3 intranasal vaccine for cattle. ii.  Mink distemper vaccine. iii.  Mink enteritis vaccine. O. Reg. 465/18, s. 2.